Clinical Trial Update: Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SBRT/Olaparib followed by Pembrolizumab/Olaparib in gastric and gastroesophageal cancers; currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Lynparza (olaparib)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Gastric Cancer, GastroEsophageal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING